Report Content
Chapter 1 Delivery Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Allergy therapeutics industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Treatment type trends
2.1.4 Type trends
2.1.5 Route of administration trends
2.1.6 Distribution channel trends
Chapter 3 Allergy Therapeutics Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of allergic conditions
3.2.1.2 Increased awareness about allergies and their impact on health
3.2.1.3 Rising advancements in biotechnology, genomics, and personalized medicine
3.2.1.4 Increasing demand for new and improved treatment options
3.2.1.5 Increasing healthcare expenditure
3.2.2 Industry pitfalls & challenges
3.2.2.1 Adverse effects and safety concerns
3.2.2.2 Lack of standardization in allergen extracts
3.2.2.3 Undiagnosed or underdiagnosed cases due to a lack of awareness, mild symptoms, or limited access to healthcare
3.3 Growth potential analysis
3.3.1 By treatment type
3.3.2 By type
3.3.3 By route of adminstration
3.3.4 By distribution channel
3.4 COVID- 19 impact analysis
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive analysis of major market players, 2022
4.5 Competitive positioning matrix, 2022
4.6 Strategic outlook matrix, 2022
Chapter 5 Allergy Therapeutics Market Size and Forecast, By Treatment type (USD Million)
5.1 Key trends, by treatment type
5.2 Anti-allergy drugs
5.2.1 Antihistamines
5.2.2 Corticosteroids
5.2.3 Decongestants
5.2.4 Other drugs
5.3 Immunotherapy
5.3.1 Sub-cutaneous immunotherapy (SCIT)
5.3.2 Sub-lingual immunotherapy (SLIT)
Chapter 6 Allergy Therapeutics Market Size and Forecast, By Type (USD Million)
6.1 Key trends, by type
6.2 Eye allergy
6.3 Asthma
6.4 Skin allergy
6.5 Food allergies
6.6 Rhinitis
6.7 Other allergy types
Chapter 7 Allergy Therapeutics Market Size and Forecast, By Route of administration (USD Million)
7.1 Key trends, by route of administration
7.2 Oral
7.3 Inhalers
7.4 Intranasal
7.5 Other routes of administration
Chapter 8 Allergy Therapeutics Market Size and Forecast, By Distribution Channel (USD Million)
8.1 Key trends, by distribution channel
8.2 Hospital pharmacies
8.3 Retail pharmacies
8.4 Other distribution channels
Chapter 9 Allergy Therapeutics Market Size and Forecast, By Region (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Allergopharma
10.2 Danaher
10.3 AbbVie, Inc.
10.4 Allergy Therapeutics plc
10.5 Sanofi SA
10.6 Pfizer, Inc.
10.7 Teva Pharmaceutical Industries Ltd.
10.8 GlaxoSmithKline plc
10.9 F. Hoffmann-La Roche Ltd.
10.10 Merck & Co., Inc.
